Reglan Adverse Events More Than Doubled from 2006 to 2008 (PRWeb via Yahoo! News) PDF Print

Recent data from the Food and Drug Administration’s Adverse Event Reporting System reveals that new cases of tardive dyskinesia or other movement disorders reported by users of Reglan (or its generic version, metoclopramide) more than doubled between 2006 and 2008.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.